• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观基因组中心:罕见病 DNA 甲基化数据分析和分类的门户。

EpigenCentral: Portal for DNA methylation data analysis and classification in rare diseases.

机构信息

Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Centre for Computational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Hum Mutat. 2020 Oct;41(10):1722-1733. doi: 10.1002/humu.24076. Epub 2020 Jul 15.

DOI:10.1002/humu.24076
PMID:32623772
Abstract

Epigenetic processes play a key role in regulating gene expression. Genetic variants that disrupt chromatin-modifying proteins are associated with a broad range of diseases, some of which have specific epigenetic patterns, such as aberrant DNA methylation (DNAm), which may be used as disease biomarkers. While much of the epigenetic research has focused on cancer, there is a paucity of resources devoted to neurodevelopmental disorders (NDDs), which include autism spectrum disorder and many rare, clinically overlapping syndromes. To address this challenge, we created EpigenCentral, a free web resource for biomedical researchers, molecular diagnostic laboratories, and clinical practitioners to perform the interactive classification and analysis of DNAm data related to NDDs. It allows users to search for known disease-associated patterns in their DNAm data, classify genetic variants as pathogenic or benign to assist in molecular diagnostics, or analyze patterns of differential methylation in their data through a simple web form. EpigenCentral is freely available at http://epigen.ccm.sickkids.ca/.

摘要

表观遗传过程在调节基因表达中起着关键作用。破坏染色质修饰蛋白的遗传变异与广泛的疾病有关,其中一些具有特定的表观遗传模式,例如异常的 DNA 甲基化 (DNAm),它可以用作疾病生物标志物。虽然大部分表观遗传学研究都集中在癌症上,但针对神经发育障碍 (NDD) 的资源却很少,其中包括自闭症谱系障碍和许多罕见的、临床重叠的综合征。为了应对这一挑战,我们创建了 EpigenCentral,这是一个面向生物医学研究人员、分子诊断实验室和临床医生的免费网络资源,用于对与 NDD 相关的 DNAm 数据进行交互式分类和分析。它允许用户在他们的 DNAm 数据中搜索已知的与疾病相关的模式,将遗传变异分类为致病性或良性以协助分子诊断,或者通过简单的网络表单分析他们数据中的差异甲基化模式。EpigenCentral 可在 http://epigen.ccm.sickkids.ca/ 免费获取。

相似文献

1
EpigenCentral: Portal for DNA methylation data analysis and classification in rare diseases.表观基因组中心:罕见病 DNA 甲基化数据分析和分类的门户。
Hum Mutat. 2020 Oct;41(10):1722-1733. doi: 10.1002/humu.24076. Epub 2020 Jul 15.
2
Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.使用 EpigenCentral 生成 DNA 甲基化特征并对罕见神经发育障碍中的变体进行分类。
Curr Protoc. 2022 Nov;2(11):e597. doi: 10.1002/cpz1.597.
3
Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.自闭症谱系障碍基因组风险位点的功能性 DNA 甲基化特征:16p11.2 缺失和 CHD8 变异。
Clin Epigenetics. 2019 Jul 16;11(1):103. doi: 10.1186/s13148-019-0684-3.
4
[Epigenetics' implication in autism spectrum disorders: A review].[表观遗传学在自闭症谱系障碍中的影响:综述]
Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28.
5
Epigenetics of Autism Spectrum Disorder.自闭症谱系障碍的表观遗传学
Adv Exp Med Biol. 2017;978:63-90. doi: 10.1007/978-3-319-53889-1_4.
6
An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.一个 HNRNPK 特异性 DNA 甲基化特征解释了错义变异,并扩展了 Au-Kline 综合征的表型谱。
Am J Hum Genet. 2022 Oct 6;109(10):1867-1884. doi: 10.1016/j.ajhg.2022.08.014. Epub 2022 Sep 20.
7
The diagnostic potential of the epigenome in autism spectrum disorders.自闭症谱系障碍中表观基因组的诊断潜力。
Epigenomics. 2021 Oct;13(20):1587-1590. doi: 10.2217/epi-2021-0338. Epub 2021 Oct 7.
8
Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort.在一个自闭症高发队列中,父系精子DNA甲基化与自闭症风险的早期迹象相关。
Int J Epidemiol. 2015 Aug;44(4):1199-210. doi: 10.1093/ije/dyv028. Epub 2015 Apr 14.
9
DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications.神经发育障碍相关的大型结构拷贝数变异的 DNA 甲基化表观遗传标志:临床意义。
Int J Mol Sci. 2022 Jul 16;23(14):7862. doi: 10.3390/ijms23147862.
10
DNA Methylation of the Oxytocin Receptor Across Neurodevelopmental Disorders.神经发育障碍中环化鸟苷酸调节蛋白受体的 DNA 甲基化。
J Autism Dev Disord. 2021 Oct;51(10):3610-3623. doi: 10.1007/s10803-020-04792-x. Epub 2021 Jan 4.

引用本文的文献

1
Diagnostic utility of single-locus DNA methylation mark in Sotos syndrome developed by nanopore sequencing-based episignature.基于纳米孔测序的表观遗传学特征所开发的单基因座DNA甲基化标记在索托斯综合征中的诊断效用。
Clin Epigenetics. 2025 Feb 18;17(1):27. doi: 10.1186/s13148-025-01832-0.
2
Expanding Upon Genomics in Rare Diseases: Epigenomic Insights.罕见病基因组学的拓展:表观基因组学见解
Int J Mol Sci. 2024 Dec 27;26(1):135. doi: 10.3390/ijms26010135.
3
Clinical evaluation of long-read sequencing-based episignature detection in developmental disorders.
基于长读长测序的发育障碍表观特征检测的临床评估
Genome Med. 2025 Jan 10;17(1):1. doi: 10.1186/s13073-024-01419-z.
4
Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.KMT2C 中的致病性变异导致一种与 Kleefstra 和 Kabuki 综合征不同的神经发育障碍。
Am J Hum Genet. 2024 Aug 8;111(8):1626-1642. doi: 10.1016/j.ajhg.2024.06.009. Epub 2024 Jul 15.
5
Advancing the Clinical and Molecular Understanding of Cornelia de Lange Syndrome: A Multidisciplinary Pediatric Case Series and Review of the Literature.推进对科妮莉亚·德朗热综合征的临床和分子理解:多学科儿科病例系列及文献综述
J Clin Med. 2024 Apr 21;13(8):2423. doi: 10.3390/jcm13082423.
6
Chromatinopathies: insight in clinical aspects and underlying epigenetic changes.染色质病:临床特征及潜在表观遗传学改变的认识。
J Appl Genet. 2024 May;65(2):287-301. doi: 10.1007/s13353-023-00824-1. Epub 2024 Jan 5.
7
Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs).全面评估神经发育障碍 (NDD) 诊断中 epi 特征的实施情况。
Hum Genet. 2023 Dec;142(12):1721-1735. doi: 10.1007/s00439-023-02609-2. Epub 2023 Oct 27.
8
Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders.表型特征在实践中的应用:对已发表的十种神经发育障碍分子诊断的表型特征进行独立评估。
Eur J Hum Genet. 2024 Feb;32(2):190-199. doi: 10.1038/s41431-023-01474-x. Epub 2023 Oct 23.
9
DNA methylation signatures for chromatinopathies: current challenges and future applications.DNA 甲基化特征在染色质病中的应用:当前挑战与未来应用。
Hum Genet. 2024 Apr;143(4):551-557. doi: 10.1007/s00439-023-02544-2. Epub 2023 Apr 6.
10
Rare diseases of epigenetic origin: Challenges and opportunities.表观遗传起源的罕见疾病:挑战与机遇
Front Genet. 2023 Feb 6;14:1113086. doi: 10.3389/fgene.2023.1113086. eCollection 2023.